Basic definitions
Sedatives/Hypnotics/Anxiolytics
Alcohol withdrawal
Opioid Use Disorder
100

Repeated use of a substance leading to clinically significant impairment within a 12‑month period

Substance Use Disorder

100

Sedation & Decreased anxiety

Intended effects of Sedatives/Hypnotics/Anxiolytics

100

Begins 4–12 hours after last intake; lasts 5–7 days.

Withdrawal

100

Reverses respiratory depression Short half‑life → may require repeat dosing.

Naloxone

200

Body adapts to a substance and experiences physical withdrawal symptoms if it is stopped abruptly.  

Dependence

200

Drowsiness, Agitation, Slurred speech, Nystagmus, Disorientation, N/V, Respiratory depression, Decreased LOC

Intoxication on Sedatives/Hypnotics/Anxiolytics

200

Occurs 2–3 days after cessationo. Medical emergency.

Delirium Tremens (DTs)

200

Full opioid agonist. Prevents withdrawal. Long‑term maintenance therapy.

Methadone

300

Compulsive use of a substance or engagement in a behavior despite harmful consequences and a lack of control.

Addiction

300

benzodiazepines, barbiturates

Examples of Sedatives/Hypnotics/ Anxiolytics

300

Tool used to assess severity of symptoms and guide medication dosing during withdrawal.

CIWA or CIWA-Ar

300

Partial agonist. Reduces cravings. Lower OD risk. For withdrawal and maintenance. Must be started in mild withdrawal.

Buprenorphine (Suboxone)

400

Experiencing physical and mental symptoms after stopping a habit-forming substance

Withdrawal

400

Antidote for benzodiazepine toxicity/overdose

Flumazenil

400

Reduce withdrawal severity and prevent seizures.

Benzodiazepines

400

Medicine approved to treat AUD and opioid use disorder by blocking opioid receptors in the brain.

Naltrexone

M
e
n
u